ES2044148T3 - Disoluciones acuosas de doxorubicina. - Google Patents

Disoluciones acuosas de doxorubicina.

Info

Publication number
ES2044148T3
ES2044148T3 ES89312625T ES89312625T ES2044148T3 ES 2044148 T3 ES2044148 T3 ES 2044148T3 ES 89312625 T ES89312625 T ES 89312625T ES 89312625 T ES89312625 T ES 89312625T ES 2044148 T3 ES2044148 T3 ES 2044148T3
Authority
ES
Spain
Prior art keywords
solutions
doxorubicin solutions
aqueous doxorubicin
aqueous
acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89312625T
Other languages
English (en)
Inventor
Murray A Kaplan
Robert K Perrone
Joseph B Bogardus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2044148T3 publication Critical patent/ES2044148T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)

Abstract

SOLUCIONES ACUOSAS ESTABLES DE FACIL UTILIZACION DE DOXORRUBICINA, QUE CONTIENEN UNA SAL DE DOXORRUBICINA FISIOLOGICAMENTE ACEPTABLE, BISULFITO DE ACETONA SODICA COMO ANTIOXIDANTE, AGUA Y, SI FUERA NECESARIO, UNA CANTIDAD SUFICIENTE DE ACIDO O BASE FISILIOLOGICAMENTE ACEPTABLE PARA AJUSTAR EL PH DE LA SOLUCION A UN RANGO APROXIMADO DE 2,5 A 6,0. DURANTE SU ALMACENAMIENTO, LAS SOLUCIONES GOZAN DE UNA ACEPTABLE DURACION QUE SUPERA LOS TRES AÑOS A UNA TEMPERATURA DE 4 (GRADOS) C.
ES89312625T 1988-12-05 1989-12-04 Disoluciones acuosas de doxorubicina. Expired - Lifetime ES2044148T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27962788A 1988-12-05 1988-12-05

Publications (1)

Publication Number Publication Date
ES2044148T3 true ES2044148T3 (es) 1994-01-01

Family

ID=23069771

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89312625T Expired - Lifetime ES2044148T3 (es) 1988-12-05 1989-12-04 Disoluciones acuosas de doxorubicina.

Country Status (20)

Country Link
EP (1) EP0372888B1 (es)
JP (1) JPH02200637A (es)
KR (1) KR920001460B1 (es)
AT (1) ATE78402T1 (es)
AU (1) AU612916B2 (es)
DD (1) DD295990A5 (es)
DE (1) DE68902223T2 (es)
DK (1) DK609889A (es)
ES (1) ES2044148T3 (es)
FI (1) FI895733A7 (es)
GR (1) GR3005391T3 (es)
HU (1) HU204704B (es)
IE (1) IE893867L (es)
IL (1) IL92541A0 (es)
NO (1) NO894811L (es)
NZ (1) NZ231602A (es)
OA (1) OA09898A (es)
PT (1) PT92483B (es)
YU (1) YU226189A (es)
ZA (1) ZA899248B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
EP3417864A4 (en) * 2016-02-16 2019-08-21 General Incorporated Association Pharma Valley Project Supporting Organisation IMMUNOSUPPRESSION TENDERING AGENT AND USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
FI883338L (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.

Also Published As

Publication number Publication date
GR3005391T3 (es) 1993-05-24
HU896426D0 (en) 1990-02-28
HUT52961A (en) 1990-09-28
AU4591589A (en) 1990-06-07
DK609889D0 (da) 1989-12-04
HU204704B (en) 1992-02-28
DK609889A (da) 1990-06-06
EP0372888B1 (en) 1992-07-22
NO894811L (no) 1990-06-06
KR900009081A (ko) 1990-07-02
DE68902223D1 (de) 1992-08-27
IL92541A0 (en) 1990-08-31
FI895733A0 (fi) 1989-11-30
YU226189A (en) 1991-02-28
PT92483A (pt) 1990-06-29
ATE78402T1 (de) 1992-08-15
PT92483B (pt) 1995-08-09
NO894811D0 (no) 1989-12-01
FI895733A7 (fi) 1990-06-06
EP0372888A1 (en) 1990-06-13
NZ231602A (en) 1991-12-23
DE68902223T2 (de) 1993-01-14
IE893867L (en) 1990-06-05
OA09898A (fr) 1994-09-15
KR920001460B1 (ko) 1992-02-14
JPH02200637A (ja) 1990-08-08
AU612916B2 (en) 1991-07-18
DD295990A5 (de) 1991-11-21
ZA899248B (en) 1990-08-29

Similar Documents

Publication Publication Date Title
ES514752A0 (es) "procedimiento para inhibir los efectos de deterioracion del oxigeno disuelto contenido en un fluido acuoso".
SE8402549L (sv) Substituerade moranolinderivat
SE7712986L (sv) Losning innehallande bestendig persyra
ES8101540A1 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos.
GB992813A (en) Sterilization solution
MX6196E (es) Procedimiento para incrementar la solubilidad en agua de una proteina de semilla vegetal
ES8305411A1 (es) Un procedimiento para la preparacion de un producto deter- gente desodorante.
ES2034365T3 (es) Una goma de mascar con blandura duradera.
ES539104A0 (es) Derivados de carboxiamidas n-glicosiladas como medios en la lucha contra las enfermedades de tipo reumatico.
ES2036179T3 (es) Procedimiento para preparar monohidrato de hidrocloruro de (s)-(-)-1-propil-2',6'-pipecoloxilidida.
EP0191357A3 (en) Treatment of eye inflammation with biphenamine
ES2196000T3 (es) Compuesto de pirroloazepina.
IT8748012A0 (it) Dispositivo emettitore di vapord'acqua da impiegare in combinazione con esche insetticide nella lotta agli scarafaggi
ES2052646T3 (es) Solucion no acuosa de hidrocloruro de doxorubicina.
ES2014428B3 (es) Nuevos derivados del acido ciclopropano carboxilico con sustituyente iodado, su preparacion, su aplicacion a la lucha contra los parasitos de vegetales y de animales y las composiciones que encierran.
AR245889A1 (es) Soluciones acuosas autoconservables para la limpieza y conservacion de las lentes de contacto blandas.
MX163472B (es) Solucion acuosa esterilizante y desinfectante que contiene glutaraldehido
ES8504182A1 (es) Procedimiento para preparar nuevos derivados de piperidina
ES8800897A1 (es) Un procedimiento para preparar el compuesto 3(s)-3-amino-2-oxo-4,4-dimetil-1-azetidinilsulfato
ES2040810T3 (es) Agentes protectores de la madera.
FR2560547B1 (fr) Composition et procede pour la protection du bois, notamment en milieu tropical marin, en particulier du bois de cocotier
ES8302458A1 (es) Procedimiento para preparar nuevas 1-substituido-6-n-propil-8-metilimidazo (1,5-d)-as-triazin-4(3h)-onas.
JPS5448711A (en) Racemization of optical active nnacyllamino acid in the atate of aqueous solution
DK609889D0 (da) Vandig doxorubicinoploesning
IT1197311B (it) Procedimento per aumentare la durata di conservazione del pesce

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 372888

Country of ref document: ES